A partnership with Ellis Fischel Cancer Center.
________________________________________________

"TBD"

Speaker: Anand Subramony, PhD Vice President,   Drug Delivery, Device, Connected Solutions & Innovation  Eli Lilly and Company Date: Thursday, March 19, 2026 4:30 p.m. - 5:30 p.m. Location: Roy Blunt NextGen Precision Health Building Atkins Family Seminar Room

 Register Here

*Zoom option available

About the Speaker

Anand Subramony is an experienced leader in the Pharma-Biotech industry, with a proven track record in biologics, combination products, medical devices, and small molecule product development. He is recognized for driving innovation and delivering complex projects with excellence.

An expert in drug delivery devices, nanomedicine, and digital health technologies, Anand Subramony has led large cross-functional teams in R&D, guiding products from concept to commercialization. He is a key opinion leader in medical devices and combination products, including profiled syringes, auto-injectors, wearable infusion systems, and connected devices. His expertise spans drug delivery technologies for small molecules, nanotechnology, oral peptides, transdermal delivery, sustained/local release, antibody-drug conjugates, AAV, and cell therapy.

About the Seminar Series

The goal of the NextGen Precision Health & Ellis Fischel Cancer Center Science Seminar is to highlight transdisciplinary precision research taking place in the cancer field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.

For questions about this event, please reach out to Mackenzie Lynch.